KKR Add to watchlist
$96.91 +0.00 (+0.00%)
Pre-Market: $97.21 +0.30 (+0.31%)
Last updated: Jul 15, 2026 09:18
52-Week Range
$97.21
$82.67 $97.21 $153.87

Fundamentals Overview

KKR & Co. Inc. is near the low of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 31.3 PEG 0.92 P/B 2.84 P/S 4.37

Intrinsic value (DCF)

-25.3% downside vs price

Profitability

Net margin 14.8%

Risk (Beta)

1.79 — higher vol

Earnings & growth

EPS $3.10 Rev -27.5% Profit -64.6% vs prior qtr

BullzEye Analysis

Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Sell — 77% confidence Risk: High Volatility — Beta 1.79. Consider smaller position size due to higher beta.

Pressures (Sell):

DCF 25.3% downside vs price · Sentiment weakening (1 downgrade) · 3M vs S&P 500: -10.5% · 3M vs Financial Services sector: -9.7% · Beta 1.79 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$87.28B
P/E (TTM)
31.32
EPS (TTM)
$3.10
Dividend Yield
0.77%
52-Week Range
$82.67 - $153.87
Volume vs Avg
N/A
Beta
1.79

About

KKR & Co. Inc. is a prominent global investment powerhouse, deeply engaged in both private equity and real estate. The firm's diverse investment strategies encompass direct capital deployment as well as fund-of-funds approaches, specializing in corporate acquisitions, leveraged and management buyouts, growth equity, and a range of special situations including credit, distressed assets, and turnarounds. They also target mature and mezzanine financing opportunities, spanning companies across the l...
Sector: Financial Services
Headquarters: US
Employees: 5,043
IPO Date: Jul 2010
Website: www.kkr.com
Beta: 1.79 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: C-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 6, Hold: 3, Outperform: 11, Overweight: 10.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $72.59; current price is $97.21. That’s a -25.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 31.32
DCF value (model) $72.59 (-25.3% vs price)
PEG (TTM) 0.92
P/B (TTM) 2.84
P/S (TTM) 4.37
P/FCF (TTM) 12.66
Liquidity & enterprise
Current Ratio (TTM) 10.06
Quick Ratio (TTM) 10.06
Cash Ratio (TTM) 10.06
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 14.82%
Gross margin (TTM) 41.75%
Operating margin (TTM) 16.29%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for KKR.

Analyst Sentiment at a Glance

C- Sentiment Weakening
Buy 6Hold 3Outperform 11Overweight 10
0 upgrades, 1 downgrade
Price Target Consensus
Current $97.21
Median $131.50
Consensus $137.75
Low consensus $112.00
High consensus $187.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
BMO Capital maintain Outperform Outperform 2026-07-13
Evercore ISI Group maintain Outperform Outperform 2026-07-13
RBC Capital maintain Outperform Outperform 2026-07-13
Barclays maintain Overweight Overweight 2026-07-10
TD Cowen maintain Hold Hold 2026-05-18
TD Cowen maintain Hold Hold 2026-05-06
UBS maintain Buy Buy 2026-05-06
RBC Capital maintain Outperform Outperform 2026-05-06
Barclays maintain Overweight Overweight 2026-05-06
Morgan Stanley maintain Overweight Overweight 2026-04-21
Evercore ISI Group maintain Outperform Outperform 2026-04-21
Oppenheimer maintain Outperform Outperform 2026-04-13
Piper Sandler maintain Overweight Overweight 2026-04-07
Goldman Sachs maintain Buy Buy 2026-04-07
BMO Capital maintain Outperform Outperform 2026-03-24
Barclays maintain Overweight Overweight 2026-03-02
UBS maintain Buy Buy 2026-02-20
Barclays maintain Overweight Overweight 2026-02-06
Oppenheimer maintain Outperform Outperform 2026-02-06
TD Cowen downgrade Buy Hold 2026-01-14
UBS maintain Buy Buy 2026-01-13
Barclays maintain Overweight Overweight 2026-01-09
Barclays maintain Overweight Overweight 2025-12-12
Barclays maintain Overweight Overweight 2025-11-11
TD Cowen maintain Buy Buy 2025-11-10
Oppenheimer maintain Outperform Outperform 2025-11-10
Morgan Stanley maintain Overweight Overweight 2025-10-21
Oppenheimer maintain Outperform Outperform 2025-10-14
Citigroup maintain Buy Buy 2025-10-13
Keefe, Bruyette & Woods maintain Outperform Outperform 2025-08-04